Subclinical hypothyroidism treatment

What to do about mild hypothyroidism is a subject that has been studied and debated for years. Mild hypothyroidism is also called subclinical hypothyroidism. It doesn't meet the standard definition of overt hypothyroidism. You may have no symptoms, and your thyroid function blood tests show a mixed picture. Your free T4 level is normal, meaning your body is getting enough thyroid hormone. It is your TSH (thyroid stimulating hormone) level that is above the normal range, which indicates your thyroid gland has to work harder to pump out that thyroid hormone. One worry about mild hypothyroidism is the potential link between untreated subclinical hypothyroidism and However, there are potential downsides to treating subclinical hypothyroidism. There is the risk of overtreatment, which might cause symptoms, such as feeling jittery and insomnia. Also, long-term overtreatment can lead to loss of bone density. If your TSH level is elevated to between 5.5 and 10 mIU/L and your T4 is still in the normal range, you and your doctor will consider starting thyroid medication or repeating the TSH later on. If you have symptoms of hypothyroidism or you have a positive test for anti-thyroid antibodies, you might want to start thyroid pills right away. If you aren't treated, your doctor should continue to monitor your thyroid function with blood tests every six to 12 months. If your TSH level is higher than 10 mIU/L, you should start treatment, because you will very likely develop symptoms o...

Background Subclinical hypothyroidism is a thyroid disorder diagnosed from the laboratory blood test results of otherwise asymptomatic patients. It has been associated with poor cardiovascular outcomes, mortality and progression to overt thyroid hormone deficiency. Current guidelines on the management of subclinical hypothyroidism differ because of conflicting evidence on long-term treatment benefits. Even though there are several existing systematic reviews on its clinical outcomes, no definitive conclusion has been reached yet. As such, a new synthesis could help provide more insight and consensus on this topic. To this purpose, this umbrella review will evaluate and synthesise current evidence on the long-term clinical outcomes of the different management strategies for subclinical hypothyroidism. Methods This is a protocol for an umbrella review on the management strategies for subclinical hypothyroidism. We will conduct literature searches in multiple electronic databases (from inception onwards), namely MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Database of Systematic Reviews, JBI Evidence Synthesis, Epistemonikos database, PDQ Evidence and the PROSPERO register. There will be no restriction on the date or language of publication. Additional material will be identified through grey literature searches and citation chaining. Review inclusion criteria will be patients with subclinical hypothyroidism, receiving treatment or monitoring, no restrictions on the comp...